Rain Therapeutics' Series A Round

Rain Therapeutics raised a round of funding on May 02, 2018.

Rain Therapeutics is focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.…

Articles about Rain Therapeutics' Series A Round: